ABN AMRO Investment Solutions
RDY icon

ABN AMRO Investment Solutions’s Dr. Reddy's Laboratories RDY Stock Holding History

ABN AMRO Investment Solutions’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-20,615
Closed -$328K – 483
2024
Q3 		$328K Buy
20,615
+3,500
+20% +$56.3K 0.01% 432
2024
Q2 		$261K Sell
17,115
-27,835
-62% -$399K ﹤0.01% 438
2024
Q1 		$659K Buy
44,950
+2,500
+6% +$36.5K 0.01% 330
2023
Q4 		$591K Sell
42,450
-4,000
-9% -$53.5K 0.01% 334
2023
Q3 		$621K Buy
+46,450
New +$628K 0.01% 322

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

ABN AMRO Investment Solutions's RDY Position: Q4 2024 in Review

ABN AMRO Investment Solutions sold out of Dr. Reddy's Laboratories (RDY) in Q4 2024, closing a stake of 20,615 shares — an estimated $328K sold.

ABN AMRO Investment Solutions first reported a position in RDY in Q3 2023 and held it in 5 quarters. The position peaked at $659K in Q1 2024. 248 funds tracked by Wall St. Rank hold RDY as of Q4 2024.

  • ABN AMRO Investment Solutions reported no remaining Dr. Reddy's Laboratories position as of Q4 2024 after selling out during the quarter.
  • ABN AMRO Investment Solutions sold 20,615 Dr. Reddy's Laboratories shares in Q4 2024, an estimated $328K.
  • ABN AMRO Investment Solutions first reported a position in Dr. Reddy's Laboratories in Q3 2023 and held it in 5 quarters.
  • ABN AMRO Investment Solutions's Dr. Reddy's Laboratories position peaked at $659K in Q1 2024.
  • 248 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2024.

Based on ABN AMRO Investment Solutions's 13F filing for Q4 2024, filed 4 Sep 2025.